MIRA
INFORM REPORT
|
Report Date : |
04.10.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ZENUFA
LABORATORIES SPRL |
|
|
|
|
Registered Office : |
P O Box 15110 Kinshasa |
|
|
|
|
Country : |
Congo |
|
|
|
|
Date of Incorporation : |
14.6.1992 |
|
|
|
|
Com. Reg. No.: |
16B791 Congo |
|
|
|
|
Legal Form : |
Limited Liability company, Limited by Shares |
|
|
|
|
Line of Business : |
Manufacturers and Distributors of Pharmaceutical Products etc |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 80,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
ZENUFA
LABORATORIES SPRL
Principal Address
P O Box 15110 Kinshasa, Congo
Telephone: +243-8844567/8843190/8845671
Fax: +243-8821210
Email: info@zenufa.com
or naren@zenufa.com
Internet: www.zenufa.com
Established
14/6/1992
Registration
No. 16B791 Congo
Legal Form
Limited Liability
company, Limited by shares
Stock Listing
Not Listed
Workforce
2007
80
Office & Factories
Head offices No. 3 Avenue
Des Entrepots, Kingabwa, Kinshasa, DRC Congo
Branches None
Company Profile
Paid in Capital CDF. 100,000,000
Subscribed Capital CDF. 100,000,000
Shareholders
Name Position Amount
Ratio
Mr. Naren Varsani CEO 40.00%
Mr. Satnam Singh Alag M
Director 40.00%
Mr. Premnath
Karkera Director 20.00%
Mr. Sanjay Singh Director
Total 100.00%
Credit Opinion
Our proposed
credit amount of USD 80,000 is recommendable
Affiliated Companies
Company (1) ZENUFA
LABORATORIES (TZ) LTD
Management/ Directors
|
President/
CEO (1) |
|
|
Name |
Mr. Naren Varsani |
|
Remarks |
Top Decision Maker |
|
President/
CEO (2) |
|
|
Name |
Mr. Satnam Singh Alag |
Þ Top decision maker is the person who has the
ultimate authority or power to make important managerial decisions. He/She may
or may not be officially registered as a president or an executive director.
Business Activities
Manufacturers
& distributors of pharmaceutical products etc
Terms of payment
Buying terms 70%
in cash, 30% on LC, TT
Selling terms 50% in cash, 50% on credit
Suppliers
None
Customers
Local agencies , stores and
outlets
Recent Sales
CDF. 1,420,000,000
(2007)
Exports
None
Export Ratio
0.0%
Import Ratio
20.0%
Domestic Market Share
20.0%
Banking relationship
Main Banks CITI Bank
Credit Check of Subject,
President & CEO (as of report date)
Payment Morale: In the documents at our disposal
nothing adverse has been shown so far.
CREDIT RATING: Financial situation is
average.
COMMENTS
Maximum credit we recommend is USD 80,000 outstanding at any one time.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.88 |
|
UK Pound |
1 |
Rs.82.97 |
|
Euro |
1 |
Rs.64.99 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)